XML 21 R10.htm IDEA: XBRL DOCUMENT v3.20.2
Investment Securities
9 Months Ended
Sep. 30, 2020
Investments, Debt and Equity Securities [Abstract]  
Investment Securities Investment Securities
Following is a comparison of the amortized cost and fair value of securities available-for-sale, as of September 30, 2020 and December 31, 2019:
(in 000's) Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value (Carrying Amount)
September 30, 2020
Securities available-for-sale:
U.S. Government agencies$35,039 $155 $(252)$34,942 
U.S. Government sponsored entities & agencies collateralized by mortgage obligations42,054 857 (14)42,897 
Asset-backed securities3,866 — (38)3,828 
Municipal bonds1,045 13 — 1,058 
Corporate bonds5,000 192 — 5,192 
Total securities available for sale$87,004 $1,217 $(304)$87,917 

(in 000's) Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value (Carrying Amount)
December 31, 2019
Securities available-for-sale:
U.S. Government agencies$28,737 $152 $(190)$28,699 
U.S. Government sponsored entities & agencies collateralized by mortgage obligations47,824 120 (331)47,613 
Total securities available for sale$76,561 $272 $(521)$76,312 
 
The amortized cost and fair value of securities available for sale at September 30, 2020, by contractual maturity, are shown below. Actual maturities may differ from contractual maturities because issuers have the right to call or prepay obligations with or without call or prepayment penalties. Contractual maturities on collateralized mortgage obligations cannot be anticipated due to allowed paydowns.
 September 30, 2020
 Amortized CostFair Value (Carrying Amount)
(in 000's)
Due in one year or less$— $— 
Due after one year through five years300 300 
Due after five years through ten years18,224 18,332 
Due after ten years26,426 26,388 
Collateralized mortgage obligations42,054 42,897 
 $87,004 $87,917 

There were no realized gains or losses on sales of available-for-sale securities for the three and nine month periods ended September 30, 2020 and September 30, 2019. There were no other-than-temporary impairment losses for the three and nine month periods ended September 30, 2020 and September 30, 2019.

At September 30, 2020, available-for-sale securities with an amortized cost of approximately $79,013,000 (fair value of $79,942,000) were pledged as collateral for FHLB borrowings, securitized deposits, and public funds balances.
The following summarizes temporarily impaired investment securities:
(in 000's)Less than 12 Months12 Months or MoreTotal
September 30, 2020Fair Value (Carrying Amount) Unrealized LossesFair Value (Carrying Amount) Unrealized LossesFair Value (Carrying Amount) Unrealized Losses
Securities available for sale:
U.S. Government agencies$9,540 $(83)17,897 (169)$27,437 $(252)
U.S. Government sponsored entities & agencies collateralized by mortgage obligations317 (2)2,068 (12)2,385 (14)
Corporate bonds— — — — — — 
Municipal bonds300 — — — 300 — 
Asset-backed securities3,828 (38)— — 3,828 (38)
Total impaired securities$13,985 $(123)$19,965 $(181)$33,950 $(304)
December 31, 2019      
Securities available for sale:      
U.S. Government agencies$3,961 $(12)$15,989 $(178)$19,950 $(190)
U.S. Government sponsored entities & agencies collateralized by mortgage obligations25,400 (187)11,244 (144)36,644 (331)
Total impaired securities$29,361 $(199)$27,233 $(322)$56,594 $(521)
 
Temporarily impaired securities at September 30, 2020, were comprised of one asset-backed security, three municipal bonds, twelve U.S. government agency securities, and four U.S. government sponsored entities and agencies collateralized by mortgage obligations securities.

The Company evaluates investment securities for other-than-temporary impairment (OTTI) at least quarterly, and more frequently when economic or market conditions warrant such an evaluation. The investment securities portfolio is evaluated for OTTI by segregating the portfolio into two general segments and applying the appropriate OTTI model. Investment securities classified as available-for-sale or held-to-maturity are generally evaluated for OTTI under ASC Topic 320, Investments – Debt and Equity Instruments.

The Company considers many factors in determining OTTI, including: (1) the length of time and the extent to which the fair value has been less than cost, (2) the financial condition and near-term prospects of the issuer, (3) whether the market decline was affected by macroeconomic conditions, and (4) whether the Company has the intent to sell the debt security or more likely than not will be required to sell the debt security before its anticipated recovery. The assessment of whether an other-than-temporary decline exists involves a high degree of subjectivity and judgment and is based on the information available to the Company at the time of the evaluation.
 
Additionally, OTTI occurs when the Company intends to sell the security or more likely than not will be required to sell the security before recovery of its amortized cost basis less any current-period credit loss. If the Company intends to sell or more likely than not will be required to sell the security before recovery of its amortized cost basis less any current-period credit loss, the other-than-temporary-impairment shall be recognized in earnings equal to the entire difference between the investment’s amortized cost basis and its fair value at the balance sheet date. If the Company does not intend to sell the security and it is not more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis less any current-period loss, the other-than-temporary-impairment shall be separated into the amount representing the credit loss and the amount related to all other factors. The amount of the total other-than-temporary-impairment related to the credit loss is recognized in earnings, and is determined based on the difference between the present value of cash flows expected to be
collected and the current amortized cost of the security. The amount of the total other-than-temporary-impairment related to other factors shall be recognized in other comprehensive (loss) income, net of applicable taxes. The previous amortized cost basis less the other-than-temporary-impairment recognized in earnings shall become the new amortized cost basis of the investment.

Management periodically evaluates each available-for-sale investment security in an unrealized loss position to determine if the impairment is temporary or other-than-temporary.

At September 30, 2020, the decline in fair value of the one asset-backed security, three municipal bonds, twelve U.S. government agency securities, and the four U.S. government sponsored entities and agencies collateralized by mortgage obligations securities is attributable to changes in interest rates, and not credit quality. Because the Company does not intend to sell these impaired securities, and it is more likely than not that it will not be required to sell these securities before its anticipated recovery, the Company does not consider these securities to be other-than-temporarily impaired at September 30, 2020.

During the nine months ended September 30, 2020 and 2019, the Company recognized $89,000 and $128,000 of unrealized holding gains related to equity securities in the consolidated statements of income, respectively. For the quarters ended September 30, 2020 and September 30, 2019, the Company recognized unrealized holding gains of $4,000 and $18,000, respectively.

The Company had no held-to-maturity or trading securities at September 30, 2020 or December 31, 2019.